Compare Alcon AG (ALC) vs Docusign Inc (DOCU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs Docusign Inc — how do they compare? Alcon AG trades at $74.19 (market cap $36.44B), while Docusign Inc trades at $58.39 (market cap $11.33B). The key difference: Alcon AG is far larger — about 3.2× Docusign Inc's market cap, and Alcon AG pays a 0.48% dividend while Docusign Inc pays none. Which is the better fit depends on your goals.
| ALC | DOCU | |
|---|---|---|
Market Cap | $36.44B | $11.33B |
Sector | Health | Technology |
52-Week High | $90.12 | $85.01 |
52-Week Low | $62.02 | $41.75 |
Enterprise Value | $40.28B | $10.70B |
Dividend Yield | 0.48% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Docusign Inc
DocuSign offers the Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its IPO in May 2018.
Read more on DOCU →
